Kefang Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kefang Sun has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chaohui Jin
Zhejiang Herymed Technology Co., Ltd., Hangzhou, China; Hithink Flush Information Network Co., Ltd., Hangzhou, China
2 shared publications - Lan Li
Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
2 shared publications - Ming Chen
Hithink RoyalFlush Information Network Company Ltd., Hangzhou, China
2 shared publications - Chaohui Yu
Department of Gastroenterology the First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China
1 shared publication H. He
People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
1 shared publication- Huogen Wang
Hithink RoyalFlush Information Network Co., Ltd, Hangzhou, China
1 shared publication
Latest Publications
- 24 March 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (7) , 553-558
Convolutional neural network for identifying common bile duct stones based on magnetic resonance cholangiopancreatography
- 24 March 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (7) , 553-558
Convolutional neural network for identifying common bile duct stones based on magnetic resonance cholangiopancreatography
- Open Access
- 16 December 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-8
Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study
Background: To improve the eradication rate of H. pylori, researchers have investigated the role of WeChat-based mini-app as an electronic reminding system in H. pylori treatment. Methods: Subjects from three medical centers were divided into two groups. Patients in the daily mini-app-based notification system group received daily notifications via the WeChat mini-app. Patients in the control group received one-time verbal education on the first clinical visit. Both groups received a 14-day quadruple therapy to eradicate H. pylori infection. Eradication rate, compliance, adverse events and satisfaction were evaluated. Results: Both intention-to-treat (ITT) and per-protocol (PP) analyses were conducted. The eradication rate in the daily mini-app-based notification system group was slightly higher compared with the control group (ITT analysis: 76.70% vs. 70.73%, p = 0.312; PP analysis: 85.87% vs. 82.86%, p = 0.562). The compliance was significantly higher in the daily mini-app-based notification system group (ITT analysis: 85.52% vs. 70.48%, p = 0.028; PP analysis: 92.39% vs. 81.90%, p = 0.030). The adverse event rates were similar between the two groups (PP analysis: 36.96% vs. 40.95%, p = 0.566). No significant difference in eradication rate was seen in each subgroup analysis by age, place of residence, grade of education, or endoscopic findings. Conclusion: The study showed that daily mini-app-based notification improved patient compliance but not H. pylori eradication rate. Trial registration The research was registered in the Chinese Clinical Trial Registry (ChiCTR2000031011, 21/03/2020).
- 16 December 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-8
Open AccessApplication of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study
Background: To improve the eradication rate of H. pylori, researchers have investigated the role of WeChat-based mini-app as an electronic reminding system in H. pylori treatment. Methods: Subjects from three medical centers were divided into two groups. Patients in the daily mini-app-based notification system group received daily notifications via the WeChat mini-app. Patients in the control group received one-time verbal education on the first clinical visit. Both groups received a 14-day quadruple therapy to eradicate H. pylori infection. Eradication rate, compliance, adverse events and satisfaction were evaluated. Results: Both intention-to-treat (ITT) and per-protocol (PP) analyses were conducted. The eradication rate in the daily mini-app-based notification system group was slightly higher compared with the control group (ITT analysis: 76.70% vs. 70.73%, p = 0.312; PP analysis: 85.87% vs. 82.86%, p = 0.562). The compliance was significantly higher in the daily mini-app-based notification system group (ITT analysis: 85.52% vs. 70.48%, p = 0.028; PP analysis: 92.39% vs. 81.90%, p = 0.030). The adverse event rates were similar between the two groups (PP analysis: 36.96% vs. 40.95%, p = 0.566). No significant difference in eradication rate was seen in each subgroup analysis by age, place of residence, grade of education, or endoscopic findings. Conclusion: The study showed that daily mini-app-based notification improved patient compliance but not H. pylori eradication rate. Trial registration The research was registered in the Chinese Clinical Trial Registry (ChiCTR2000031011, 21/03/2020).